One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?
Nat Biotechnol
.
2020 Mar;38(3):279-283.
doi: 10.1038/s41587-020-0440-4.
Authors
Mateo Aboy
1
,
Cristina Crespo
2
,
Kathleen Liddell
2
,
Neil Davey
2
,
Johnathon Liddicoat
2
,
Timo Minssen
3
Affiliations
1
Centre for Law, Medicine, and Life Sciences (LML), Faculty of Law, University of Cambridge, Cambridge, UK. ma608@cam.ac.uk.
2
Centre for Law, Medicine, and Life Sciences (LML), Faculty of Law, University of Cambridge, Cambridge, UK.
3
Center for Advanced Studies in Biomedical Innovation Law (CeBIL), University of Copenhagen, Copenhagen, Denmark.
PMID:
32152571
DOI:
10.1038/s41587-020-0440-4
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Diagnostic Test Approval / legislation & jurisprudence*
Humans
Patents as Topic / legislation & jurisprudence*